These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
666 related articles for article (PubMed ID: 3486118)
1. The effect of vitamin D on bone in vivo. Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats. Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D metabolites do not alter parathyroid hormone secretion acutely. Magliola L; Anast CS; Forte LR Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783 [TBL] [Abstract][Full Text] [Related]
4. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3. Yamato H; Matsumoto T; Fukumoto S; Ikeda K; Ishizuka S; Ogata E Endocrinology; 1989 Jan; 124(1):511-7. PubMed ID: 2783309 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolites and bone mineralization in man. Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606 [TBL] [Abstract][Full Text] [Related]
6. The relationship between bone apposition rate and vitamin D activity in phosphate-deficient rats. Harrison JE; Tam CS; Hitchman AJ; Hitchman A; Hasany SA; Jones G Metabolism; 1986 Feb; 35(2):126-9. PubMed ID: 3484801 [TBL] [Abstract][Full Text] [Related]
7. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone. Marcus R; Orner FB; Brickman AS Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269 [TBL] [Abstract][Full Text] [Related]
8. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3. Mortensen BM; Gautvik KM; Gordeladze JO Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394 [TBL] [Abstract][Full Text] [Related]
9. Developmental changes in the responsiveness of rat kidney to vitamin D metabolites. Sömjen D; Weisman Y; Berger E; Earon Y; Kaye AM; Binderman I Endocrinology; 1986 Jan; 118(1):354-9. PubMed ID: 3000745 [TBL] [Abstract][Full Text] [Related]
10. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat. Vukicević S; Bagi C; Vujicić G; Krempien B; Stavljenić A; Herak M Bone Miner; 1986 Oct; 1(5):383-96. PubMed ID: 3509782 [TBL] [Abstract][Full Text] [Related]
11. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat. Lemay J; Gascon-Barré M Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257 [TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia]. Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067 [TBL] [Abstract][Full Text] [Related]
14. Effects of vitamin D3, 25-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion. Cantley LK; Russell JB; Lettieri DS; Sherwood LM Calcif Tissue Int; 1987 Jul; 41(1):48-51. PubMed ID: 3040201 [TBL] [Abstract][Full Text] [Related]
15. Conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in renal slices from the rat. Armbrecht HJ; Zenser TV; Davis BB Endocrinology; 1981 Jul; 109(1):218-22. PubMed ID: 6972300 [TBL] [Abstract][Full Text] [Related]
16. Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats. Lian JB; Carnes DL; Glimcher MJ Endocrinology; 1987 May; 120(5):2123-30. PubMed ID: 3494594 [TBL] [Abstract][Full Text] [Related]
17. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728 [TBL] [Abstract][Full Text] [Related]
18. Activity of ornithine decarboxylase and creatine kinase in soft and hard tissue of vitamin D-deficient chicks following parenteral application of 1,25-dihydroxyvitamin D3 or 24R,25-dihydroxyvitamin D3. Ittel TH; Ross FP; Norman AW J Bone Miner Res; 1986 Feb; 1(1):23-31. PubMed ID: 3509739 [TBL] [Abstract][Full Text] [Related]
19. Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. Halloran BP; Bikle DD; Levens MJ; Castro ME; Globus RK; Holton E J Clin Invest; 1986 Sep; 78(3):622-8. PubMed ID: 3489007 [TBL] [Abstract][Full Text] [Related]
20. The effect of vitamin D restriction and repletion on bone apposition in the rat and its dependence on parathyroid hormone. Tam CS; Jones G; Heersche JN Endocrinology; 1981 Nov; 109(5):1448-53. PubMed ID: 6271531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]